Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Combined Immunodeficiency”

1,047 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,047 results

Large-scale testing (Phase 3)Study completedNCT00234910
What this trial is testing

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Who this might be right for
HIV Infection
Abbott 152
Early research (Phase 1)Study completedNCT00001010
What this trial is testing

Zidovudine Plus Acyclovir in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 72
Not applicableNot Yet RecruitingNCT07388979
What this trial is testing

MAGIA H3S Point of Care Test Performance for HIV, HBV, HCV, and Syphilis Screening in Pregnant Women in DR Congo

Who this might be right for
HIV - Human Immunodeficiency VirusHBV (Hepatitis B Virus)Hepatitis C Virus (HCV)+5 more
Gardiens de Vies 7,500
Early research (Phase 1)Study completedNCT01982396
What this trial is testing

Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children

Who this might be right for
HIV Infection
PENTA Foundation 19
Post-approval studies (Phase 4)Study completedNCT00442962
What this trial is testing

HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV

Who this might be right for
HIV Infections
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 54
Not applicableStudy completedNCT00002331
What this trial is testing

The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS

Who this might be right for
Mycobacterium Avium-intracellular InfectionHIV Infections
Abbott
Not applicableStudy completedNCT00001131
What this trial is testing

Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Testing effectiveness (Phase 2)Ended earlyNCT00196651
What this trial is testing

HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides in Patients Treated Early With HAART During Primary Infection

Who this might be right for
HIV Infection
French National Agency for Research on AIDS and Viral Hepatitis 60
Not applicableStudy completedNCT00002056
What this trial is testing

A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral / Oral Trimethoprim - Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia in AIDS

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
LyphoMed
Testing effectiveness (Phase 2)Study completedNCT00827112
What this trial is testing

A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients

Who this might be right for
Human Immunodeficiency Virus-1
ViiV Healthcare 129
Early research (Phase 1)Ended earlyNCT00006153
What this trial is testing

Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 45
Testing effectiveness (Phase 2)Study completedNCT00002239
What this trial is testing

Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults

Who this might be right for
HIV Infections
Hoffmann-La Roche 68
Early research (Phase 1)Study completedNCT02022696
What this trial is testing

Treatment of SCID Due to ADA Deficiency With Autologous Transplantation of Cord Blood or Hematopoietic CD 34+ Cells After Addition of a Normal Human ADA cDNA by the EFS-ADA Lentiviral Vector

Who this might be right for
Adenosine Deaminase DeficiencyADA-SCID
National Human Genome Research Institute (NHGRI) 1
Large-scale testing (Phase 3)Study completedNCT00272779
What this trial is testing

BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada

Who this might be right for
HIV Infections
Bristol-Myers Squibb 1,057
Testing effectiveness (Phase 2)Ended earlyNCT00144105
What this trial is testing

A Randomised Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir (TPV) Plus 100 mg or 200 mg Ritonavir (RTV) p.o. BID in Comparison to 400 mg Lopinavir (LPV) Plus 100 mg RTV p.o. BID in Combination With Standard Background Regimen in ARV Therapy naïve Patients.

Who this might be right for
HIV Infections
Boehringer Ingelheim 562
Testing effectiveness (Phase 2)Ended earlyNCT00104429
What this trial is testing

GW873140 In Combination With Combivir In HIV Infected Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 125
Early research (Phase 1)Study completedNCT00006325
What this trial is testing

Safety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 54
Testing effectiveness (Phase 2)Looking for participantsNCT03538899
What this trial is testing

Autologous Gene Therapy for Artemis-Deficient SCID

Who this might be right for
Severe Combined Immunodeficiency
University of California, San Francisco 24
Not applicableStudy completedNCT00002375
What this trial is testing

Safety and Effectiveness of Giving Indinavir and Nelfinavir to HIV-Infected Patients

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 24
Not applicableStudy completedNCT06155019
What this trial is testing

Switch From Etravirine to Doravirine as a Part of Antiretroviral Combination

Who this might be right for
HIV Infections
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida 109
Load More Results